Last SFr.178.50 CHF
Change Today +10.30 / 6.12%
Volume 24.9K
COPN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
As of 3:24 PM 08/19/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Via Cristoforo Colombo, 1

Lainate, MI 20020

Italy

Phone: 39 0293 33 76 14

Fax: 39 0293 33 76 63

Cosmo Pharmaceuticals S.p.A. operates as a specialty pharmaceutical company primarily in Italy. The company develops, licenses, and commercializes proprietary pharmaceutical products, primarily for the treatment of inflammatory bowel diseases, colon infections, and other colon diseases, as well as topically treated skin disorders; and manufactures pharmaceutical products for third parties and provides related services. Its products comprise Lialda, Mezavant, and Mesavancol proprietary formulations for mild to moderate ulcerative colitis; Zacol NMX for intestinal disorders; Uceris and Cortiment products for ulcerative colitis; and Low Molecular Weight Heparin MMX for the treatment of Ulcerative Colitis. The company also develops various products, including Rifamycin SV MMX, which is under Phase III clinical trials and is intended for use as an antibiotic; CB-03-01, a steroidal ester, androgen antagonist that is under Phase II clinical trials; CB-17-01, a coloring agent that is used to stain the mucosa to discover pre-cancerous lesions and polyps in the colon and has completed Phase II clinical trials; and CB-01-16, which is under Phase I clinical trials and is intended for the treatment of opioid induced constipation. It has a strategic collaboration agreement with Santarus Inc. The company is headquartered in Lainate, Italy.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COPN:SW SFr.178.50 CHF +10.30

COPN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $44.04 USD +0.05
Depomed Inc $14.94 USD +1.78
Durect Corp $1.55 USD 0.00
Supernus Pharmaceuticals Inc $8.96 USD -0.05
Veloxis Pharmaceuticals A/S kr1.87 DKK +0.01
View Industry Companies
 

Industry Analysis

COPN

Industry Average

Valuation COPN Industry Range
Price/Earnings 23.9x
Price/Sales 27.2x
Price/Book 11.1x
Price/Cash Flow 24.7x
TEV/Sales 27.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COSMO PHARMACEUTICALS SPA, please visit www.cosmopharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.